Inactive

The purpose of this sole source within scope modification to Siga Technologies Inc., is to procure additional doses of TPOXX thereby replenishing existing National Stockpile quantities. TPOXX is an or... The purpose of this sole source within scope modification to Siga Technologies Inc., is to procure additional doses of TPOXX thereby replenishing existing National Stockpile quantities. TPOXX is an oral Smallpox Treatment in capsule form, approved by the United States Food and Drug Administration in 2018.